Frédéric Massé

2.3k citations

22 papers · 1.4k indexed · h-index 18

Impact in

Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry
Cancer Research top 10%
- Protease and Inhibitor Mechanisms

Papers in ⓘ

Cancer Research 8
- Protease and Inhibitor Mechanisms 8
Immunology and Allergy 3
- Cell Adhesion Molecules Research 3

Co-authors: W. Cameron Black (12 shared papers)Raphaël Roduit (3 shared papers)Sylvie Desmarais (9 shared papers)M. David Percival (8 shared papers)Jean‐Pierre Falgueyret (6 shared papers)Neil B. Ruderman (2 shared papers)Marc Prentki (2 shared papers)Denis Riendeau (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Medicinal Chemistry (3 papers)Journal of Biological Chemistry (2 papers)SLAS DISCOVERY (1 paper)ACS Medicinal Chemistry Letters (1 paper)
Partner nations: Canada United States Switzerland

In The Last Decade

Frédéric Massé

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Frédéric Massé

Since Specialization

Citations

This map shows the geographic impact of Frédéric Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Massé more than expected).

Fields of papers citing papers by Frédéric Massé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Massé. The network helps show where Frédéric Massé may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Massé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Massé Line = papers co-authored together Frédéric Massé links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimuli Diabetes ·Raphaël Roduit, Christopher J. Nolan, Cristina Alarcón, Patrick C. Moore, Annie Barbeau, Viviane Delghingaro‐Augusto, Ewa Przybykowski, Johane Morin, Frédéric Massé, Bernard Massie, Neil B. Ruderman, Christopher J. Rhodes, Vincent Poitout, Marc Prentki	2004	159
2	Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Journal of Biological Chemistry ·Asish K. Saha, Alexandria J. Schwarsin, Raphaël Roduit, Frédéric Massé, Virendar K. Kaushik, Keith Tornheim, Marc Prentki, Neil B. Ruderman	2000	154
3	Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell Journal of Biological Chemistry ·Raphaël Roduit, Johane Morin, Frédéric Massé, Laura Segall, Enrique Roche, Christopher B. Newgard, Françoise Assimacopoulos‐Jeannet, Marc Prentki	2000	138
4	Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity Journal of Medicinal Chemistry ·Jean‐Pierre Falgueyret, Sylvie Desmarais, Renata M. Oballa, W. Cameron Black, Wanda Cromlish, Karine Khougaz, Sonia Lamontagne, Frédéric Massé, Denis Riendeau, Sylvie Toulmond, M. David Percival	2005	120
5	Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Bernard Côté, Louise Boulet, Christine Brideau, David Claveau, Diane Ethier, Richard Frenette, Marc Gagnon, André Giroux, Jocelyne Guay, Sébastien Guiral, Joseph A. Mancini, Evelyn Martins, Frédéric Massé, Nathalie Méthot, Denis Riendeau, Joel Rubin, Daigen Xu, Hongping Yu, Yves Ducharme, Richard W. Friesen	2007	116
6	Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K Bioorganic & Medicinal Chemistry Letters ·W. Cameron Black, Christopher I. Bayly, Dana Davis, Sylvie Desmarais, Jean‐Pierre Falgueyret, Serge Léger, Chun Sing Li, Frédéric Massé, Daniel J. McKay, James T. Palmer, M. David Percival, Joël Robichaud, Nancy N. Tsou, Robert Zamboni	2005	111
7	Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure Antimicrobial Agents and Chemotherapy ·Momar Ndao, Christian Beaulieu, W. Cameron Black, Élise Isabel, Fabio Vasquez-Camargo, Milli Nath-Chowdhury, Frédéric Massé, Christophe Mellon, Nathalie Méthot, Deborah A. Nicoll‐Griffith	2013	75
8	The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor ACS Medicinal Chemistry Letters ·Yves Ducharme, Marc Blouin, Christine Brideau, Anne Châteauneuf, Yves Gareau, Erich L. Grimm, Hélène Jûteau, Sébastien Laliberté, Bruce Mackay, Frédéric Massé, Marc Ouellet, Myriam Salem, Angela Styhler, Richard W. Friesen	2010	70
9	Identification of a potent and selective non-basic cathepsin K inhibitor Bioorganic & Medicinal Chemistry Letters ·Chun Sing Li, Denis Deschênes, Sylvie Desmarais, Jean‐Pierre Falgueyret, Jacques Yves Gauthier, Donald B. Kimmel, Serge Léger, Frédéric Massé, Mary E. McGrath, Daniel J. McKay, M. David Percival, Denis Riendeau, Sevgi B. Rodan, Michel Thérien, Vouy-Linh Truong, Gregg Wesolowski, Robert Zamboni, W. Cameron Black	2006	67
10	Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438) Bioorganic & Medicinal Chemistry Letters ·Serge Léger, W. Cameron Black, Denis Deschênes, Sarah J. Dolman, Jean‐Pierre Falgueyret, Marc Gagnon, Sébastien Guiral, Zheng Huang, Jocelyne Guay, Yves Leblanc, Chun‐Sing Li, Frédéric Massé, Renata M. Oballa, Lei Zhang	2009	55
11	Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease Bioorganic & Medicinal Chemistry Letters ·Christian Beaulieu, Élise Isabel, Angélique Fortier, Frédéric Massé, Christophe Mellon, Nathalie Méthot, Momar Ndao, Deborah A. Nicoll‐Griffith, Doris Lee, Hyeram Park, W. Cameron Black	2010	53
12	The identification of potent, selective, and bioavailable cathepsin S inhibitors Bioorganic & Medicinal Chemistry Letters ·Jacques Yves Gauthier, W. Cameron Black, Isabelle Courchesne, Wanda Cromlish, Sylvie Desmarais, Robert Houle, Sonia Lamontagne, Chun Sing Li, Frédéric Massé, Daniel J. McKay, Marc Ouellet, Joël Robichaud, Jean‐François Truchon, Vouy-Linh Truong, Qingping Wang, M. David Percival	2007	51
13	Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools Biological Chemistry ·Sylvie Desmarais, Frédéric Massé, M. David Percival	2009	39
14	β-Substituted Cyclohexanecarboxamide: A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K Journal of Medicinal Chemistry ·Sheldon N. Crane, W. Cameron Black, James T. Palmer, Dana Davis, Eduardo L. Setti, Joël Robichaud, Julie Pâquet, Renata M. Oballa, Christopher I. Bayly, Daniel J. McKay, John R. Somoza, Natalie Chauret, Carmai Seto, John Scheigetz, Greg A. Wesolowski, Frédéric Massé, Sylvie Desmarais, Marc Ouellet	2006	31
15	Primary amides as selective inhibitors of cathepsin K Bioorganic & Medicinal Chemistry Letters ·Serge Léger, Christopher I. Bayly, W. Cameron Black, Sylvie Desmarais, Jean‐Pierre Falgueyret, Frédéric Massé, M. David Percival, Jean‐François Truchon	2007	30
16	Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael J. Boyd, Sheldon N. Crane, Joël Robichaud, John Scheigetz, W. Cameron Black, Nathalie Chauret, Qingping Wang, Frédéric Massé, Renata M. Oballa	2008	23
17	Trisubstituted ureas as potent and selective mPGES-1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Jean-François Chiasson, Louise Boulet, Christine Brideau, Anh Chau, David Claveau, Bernard Côté, Diane Ethier, André Giroux, Jocelyne Guay, Sébastien Guiral, Joseph A. Mancini, Frédéric Massé, Nathalie Méthot, Denis Riendeau, Patrick Roy, Joel Rubin, Daigen Xu, Hongping Yu, Yves Ducharme, Richard W. Friesen	2011	22
18	Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis Journal of Medicinal Chemistry ·Joël Robichaud, W. Cameron Black, Michel Thérien, Julie Pâquet, Renata M. Oballa, Christopher I. Bayly, Daniel J. McKay, Qingping Wang, Élise Isabel, Serge Léger, Christophe Mellon, Donald B. Kimmel, Gregg Wesolowski, M. David Percival, Frédéric Massé, Sylvie Desmarais, Jean‐Pierre Falgueyret, Sheldon N. Crane	2008	21
19	An Automated Multistep High-Throughput Screening Assay for the Identification of Lead Inhibitors of the Inducible Enzyme mPGES-1 SLAS DISCOVERY ·Frédéric Massé, Sébastien Guiral, Louis-Jacques Fortin, Elizabeth Cauchon, Diane Ethier, Jocelyne Guay, Christine Brideau	2005	14
20	β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core Bioorganic & Medicinal Chemistry Letters ·Joël Robichaud, Christopher I. Bayly, W. Cameron Black, Sylvie Desmarais, Serge Léger, Frédéric Massé, Daniel J. McKay, Renata M. Oballa, Julie Pâquet, M. David Percival, Jean‐François Truchon, Gregg Wesolowski, Sheldon N. Crane	2007	11

About Frédéric Massé

Frédéric Massé is a scholar working on Cancer Research, Immunology and Allergy, Toxicology, Molecular Biology and Complementary and alternative medicine, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (9 papers), Protease and Inhibitor Mechanisms (8 papers), Natural product bioactivities and synthesis (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Cell Adhesion Molecules Research (3 papers), Pancreatic function and diabetes (2 papers), Research on Leishmaniasis Studies (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Pharmaceutical Science (123 citations), Cancer Research (194 citations), Organic Chemistry (361 citations), Molecular Biology (749 citations) and Pharmacology (151 citations). Frédéric Massé has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include W. Cameron Black, Raphaël Roduit, Sylvie Desmarais, M. David Percival, Jean‐Pierre Falgueyret, Neil B. Ruderman, Marc Prentki, Denis Riendeau, Renata M. Oballa and Serge Léger. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, SLAS DISCOVERY and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact